Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Vascular Soft Tissue Sarcomas
NCT00859456Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Apr 2007
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in angiosarcoma, epithelioid hemangioendothelioma (EHE), Kaposi's sarcoma (KS), sponsored by Columbia University. Started Apr 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
angiosarcomaepithelioid hemangioendothelioma (EHE)Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00859456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859456.